CL2023001049A1 - Procedimiento para la fabricación de compuestos orgánicos - Google Patents
Procedimiento para la fabricación de compuestos orgánicosInfo
- Publication number
- CL2023001049A1 CL2023001049A1 CL2023001049A CL2023001049A CL2023001049A1 CL 2023001049 A1 CL2023001049 A1 CL 2023001049A1 CL 2023001049 A CL2023001049 A CL 2023001049A CL 2023001049 A CL2023001049 A CL 2023001049A CL 2023001049 A1 CL2023001049 A1 CL 2023001049A1
- Authority
- CL
- Chile
- Prior art keywords
- manufacture
- organic compounds
- procedure
- present application
- relates generally
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000002894 organic compounds Chemical class 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente solicitud se refiere en general a varios procesos para la fabricación de compuestos orgánicos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063090558P | 2020-10-12 | 2020-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2023001049A1 true CL2023001049A1 (es) | 2023-09-22 |
Family
ID=78536589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2023001049A CL2023001049A1 (es) | 2020-10-12 | 2023-04-12 | Procedimiento para la fabricación de compuestos orgánicos |
Country Status (17)
Country | Link |
---|---|
US (1) | US20230416252A1 (es) |
EP (1) | EP4225757A1 (es) |
JP (1) | JP2023545129A (es) |
KR (1) | KR20230106611A (es) |
CN (1) | CN117120418A (es) |
AR (1) | AR123762A1 (es) |
AU (1) | AU2021360411A1 (es) |
BR (1) | BR112023006200A2 (es) |
CA (1) | CA3195024A1 (es) |
CL (1) | CL2023001049A1 (es) |
CO (1) | CO2023005883A2 (es) |
IL (1) | IL301889A (es) |
MX (1) | MX2023004237A (es) |
PE (1) | PE20231310A1 (es) |
TW (1) | TW202229280A (es) |
UY (1) | UY39469A (es) |
WO (1) | WO2022081473A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024030409A1 (en) | 2022-08-01 | 2024-02-08 | Bristol-Myers Squibb Company | Use of milvexian for treating or preventing ischemic stroke |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO2721243T3 (es) * | 2014-10-01 | 2018-10-20 | ||
US9453018B2 (en) * | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
BR112021020368A2 (pt) * | 2019-04-11 | 2021-12-07 | Bristol Myers Squibb Co | Opções sintéticas para a fabricação de (6r,10s)-10-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1(6h)-pirimidinil}-1-(difluorometil)-6-metil-1,4,7,8,9,10-hexa-hidro-11,15-(meteno)pirazolo[4,3-b][1,7]diazaciclotetradecin-5(6h)-ona |
-
2021
- 2021-10-08 TW TW110137557A patent/TW202229280A/zh unknown
- 2021-10-11 US US18/031,277 patent/US20230416252A1/en active Pending
- 2021-10-11 AU AU2021360411A patent/AU2021360411A1/en active Pending
- 2021-10-11 WO PCT/US2021/054413 patent/WO2022081473A1/en active Application Filing
- 2021-10-11 EP EP21805719.8A patent/EP4225757A1/en active Pending
- 2021-10-11 BR BR112023006200A patent/BR112023006200A2/pt unknown
- 2021-10-11 IL IL301889A patent/IL301889A/en unknown
- 2021-10-11 CA CA3195024A patent/CA3195024A1/en active Pending
- 2021-10-11 PE PE2023001401A patent/PE20231310A1/es unknown
- 2021-10-11 MX MX2023004237A patent/MX2023004237A/es unknown
- 2021-10-11 JP JP2023521834A patent/JP2023545129A/ja active Pending
- 2021-10-11 CN CN202180069415.2A patent/CN117120418A/zh active Pending
- 2021-10-11 KR KR1020237015983A patent/KR20230106611A/ko unknown
- 2021-10-12 UY UY0001039469A patent/UY39469A/es unknown
- 2021-10-12 AR ARP210102810A patent/AR123762A1/es unknown
-
2023
- 2023-04-12 CL CL2023001049A patent/CL2023001049A1/es unknown
- 2023-05-08 CO CONC2023/0005883A patent/CO2023005883A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2023545129A (ja) | 2023-10-26 |
KR20230106611A (ko) | 2023-07-13 |
MX2023004237A (es) | 2023-07-03 |
CA3195024A1 (en) | 2022-04-21 |
AU2021360411A1 (en) | 2023-06-08 |
IL301889A (en) | 2023-06-01 |
WO2022081473A1 (en) | 2022-04-21 |
CO2023005883A2 (es) | 2023-08-09 |
US20230416252A1 (en) | 2023-12-28 |
CN117120418A (zh) | 2023-11-24 |
EP4225757A1 (en) | 2023-08-16 |
PE20231310A1 (es) | 2023-08-24 |
AR123762A1 (es) | 2023-01-11 |
UY39469A (es) | 2022-04-29 |
AU2021360411A9 (en) | 2024-06-06 |
BR112023006200A2 (pt) | 2023-05-09 |
TW202229280A (zh) | 2022-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021002382A2 (es) | Nuevos compuestos heterocíclicos como inhibidores de la monoacilglicerol lipasa | |
BR112014030365A2 (pt) | síntese de composto antiviral | |
BR112016028773A2 (pt) | processos para preparação de compostos antivirais | |
BR112017023950A2 (pt) | processo para a preparação de limonen-4-ol | |
AR116790A1 (es) | PROCEDIMIENTO PARA LA PREPARACIÓN DE 3a-HIDROXI-5a-PREGNAN-20-ONA (BREXANOLONA) | |
BR112017024249A2 (pt) | ?utilização de um composto, composição, mistura agroquímica, métodos para a redução da nitrificação e para o tratamento de um fertilizante e composto de tioéter? | |
CU23757B7 (es) | Bencilaminas, un proceso para su producción y su uso como agentes anti-inflamatorios | |
CL2023001049A1 (es) | Procedimiento para la fabricación de compuestos orgánicos | |
BR112017020484A2 (pt) | método para a fabricação de novo composto contendo nitrogênio ou sal do mesmo e intermediário de fabricação do novo composto contendo nitrogênio ou sal do mesmo | |
CL2021000903A1 (es) | Nhibidores de ror gamma (solicitud divisional de la solicitud 217-2020 | |
EA201891769A1 (ru) | СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ | |
BR112015029399A2 (pt) | produção em etapa única de uma composição de polipropileno | |
CL2020000190A1 (es) | Inhibidores de ror-gamma. | |
UY37932A (es) | Proceso para producir compuestos de piridazinona herbicidas | |
CL2019000016A1 (es) | Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble. | |
CO2020003424A2 (es) | Cristal | |
BR112015024859A2 (pt) | processo e intermediários para a preparação de pregabalina | |
NI202100055A (es) | Formas de sal y cristalinas de un compuesto orgánico y composiciones farmacéutica del mismo. | |
CL2021001511A1 (es) | Novedosa psicosa-6-fosfato fosfatasa, composición para la producción de psicosa que comprende la misma y procedimiento para la producción de psicosa mediante el uso de la misma | |
AR098879A1 (es) | Síntesis de ent-progesterona y sus productos intermedios | |
CL2023001760A1 (es) | Proceso | |
EA202190989A1 (ru) | Новый способ синтеза производных пиперазинил-этокси-бромфенила и их применение в получении содержащих их соединений | |
UY39831A (es) | Métodos para reducir la producción de metano | |
BR112023017834A2 (pt) | Inibidores de lrrk2 cinase macrocíclicos | |
BR112022002459A2 (pt) | Processo para a preparação de 2-cloro-1-(2-clorotiazol-5-il)etanona |